Takeaway: This approval cements Novo Nordisks leadership in cardiometabolic innovation, extending GLP-1based CV protection to a wider population and setting a new benchmark in diabetes and heart health management
Accessed: 19 November 2023 Nikolakopoulou A, Higgins JPT, Papakonstantinou T et al (2020) CINeMA: an approach for assessing confidence in the results of a network meta-analysis
GLP-1 medications, by comparison, cost $800$1,200 per month, adding up to $10,000+ yearly, making surgery more cost-effective long-term
We always aim to make IV hydration a safe, comfortable, and efficient process for our patients
While evidence for these claims is still emerging and must be interpreted cautiously, the convenience and ease of administration through our semisolid gel formulation might make it an attractive option for those seeking to trial such alternative uses
It connects the dermis with structures such as tendons, muscles, or bones